Weekly high-dose cisplatin in malignant pleural mesothelioma by Planting, A. S. T., Schellens, J. H. M., Goey, S. H., van der Burg, M. E. L., de Boer-Dennert, M., Stoter, G., Verweij, J.

Get full text

Five days of oral topotecan (hycamtin ®), a phase I and pharmacological study in adult patients with solid tumours by Gerrits, C.J.H, Burris, H, Schellens, J.H.M, Planting, A.S.T, van den Burg, M.E.L, Rodriguez, G.I, van Beurden, V, Loos, W.J, Hudson, I, Fields, S, Verweij, J, von Hoff, D.D

Get full text

Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative group by Sahmoud, T., Postmus, P.E., van Pottelsberghe, Ch, Mattson, K., Tammilehto, L., Splinter, T.A.W., Planting, A.S.T., Sutedja, T., van Pawel, J., van Zandwijk, N., Baas, P., Roozendaal, K.J., Schrijver, M., Kirkpatrick, A., Van Glabbeke, M., Ardizzoni, A., Giaccone, G.

Get full text

Oral ZD9331, a non-polyglutamated thymidylate synthase (TS) inhibitor: a phase I and pharmacologic study by de Jonge, M.J.A., Punt, C.J.A., Planting, A.S.T., Wagener, D.J.Th, Jackman, A., Smith, R., Smith, M., Verweij, J.

Get full text

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck by Planting, A.S.T., de Mulder, P.H.M., de Graeff, A., Verweij, J.

Get full text

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma by Planting, A. S. T., van der Burg, M. E. L., Goey, S. H., ScheUens, J. H. M., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.

Get full text

392 Randomized Phase II study of weekly cisplatin with or without amifostine in patients with advanced head and neck cancer by Planting, A.S.T., Vermorken, J.B., Catimel, G., de Mulder, P.H.M., de Graeff, A., Oster, W., Verdonk, H.E.R.

Get full text

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors by Planting, A. S. T., van der Burg, M. E. L., de Boer-Dennert, M., Stoter, G., Verweij, J.

Get full text

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration by Hilkens, P.H.E., van der Burg, M.E.L., Moll, J.W.B., Planting, A.S.T., van Putten, W.L.J., Vecht, Ch.J., van den Bent, M.J.

Get full text

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma by Planting, A.S.T., van der Burg, M.E.L., Goey, S.H., Schellens, J.H.M., Vecht, Ch, de Boer-Dennert, M., Stoter, G., Verweij, J.

Get full text

48 Phase II trials of etoposide in malignant pleural mesothelioma by Sahmoud, T., Postmus, P.E., van Pottelsberghe, Ch, Mattson, K., Tammilehto, L., Splinter, T.A.W., Planting, A.S.T., Sutedja, T., van Pawel, J., van Zandwijk, N., Baas, P., Roozendaal, K.J., Schrijver, M., Kirkpatrick, A., Van Glabbeke, M., Ardizzoni, A., Giaccone, G.

Get full text

Efficacy and side effects of two chemotherapy regimens with cisplatin plus fluorouracil in advanced squamous cell carcinoma of the head and neck by Planting, A.S.T., van Sichem, C. K., Schmitz, P.I.M., Meeuwis, C.M., Stoter, G., Verweij, J.

Get full text